281 related articles for article (PubMed ID: 22402359)
21. Primary renal non-Hodgkin lymphoma: an unusual diagnosis for a renal mass.
Belbaraka R; Elyoubi MB; Boutayeb S; Errihani H
Indian J Cancer; 2011; 48(2):255-6. PubMed ID: 21768678
[No Abstract] [Full Text] [Related]
22. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
23. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
George A; Tam CS; Seymour JF
Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
[No Abstract] [Full Text] [Related]
24. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
Dai CW; Zhang GS; Pei MF; Shen JK
Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
[No Abstract] [Full Text] [Related]
25. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
[No Abstract] [Full Text] [Related]
26. Treatment of a patient with adnexal lymphoma with Rituximab.
Bilgir O; Bilgir F; Calan M; Yuksel A; Sari F; Oztekin O
Transfus Apher Sci; 2011 Apr; 44(2):135-7. PubMed ID: 21320802
[TBL] [Abstract][Full Text] [Related]
27. CHOP plus rituximab--balancing facts and opinion.
Cheson BD
N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
[No Abstract] [Full Text] [Related]
28. Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.
Senapati J; Devasia AJ; Sudhakar S; Viswabandya A
Ann Hematol; 2014 Sep; 93(9):1599-602. PubMed ID: 24362455
[No Abstract] [Full Text] [Related]
29. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
Fowler NH
Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
[No Abstract] [Full Text] [Related]
30. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
31. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
32. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
[No Abstract] [Full Text] [Related]
33. IgA monoclonal gammopathy accompanying extranodal B cell lymphomas.
Wu B; Chen P; Wang W; Li F; Zou S; Cheng Y
Ann Hematol; 2014 Mar; 93(3):521-2. PubMed ID: 23793917
[No Abstract] [Full Text] [Related]
34. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
[No Abstract] [Full Text] [Related]
35. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
[No Abstract] [Full Text] [Related]
36. Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria.
Rashidi A; Oak E; Carson KR; Wagner-Johnston ND; Kreisel F; Bartlett NL
Leuk Lymphoma; 2016 May; 57(5):1191-3. PubMed ID: 26397936
[No Abstract] [Full Text] [Related]
37. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
[No Abstract] [Full Text] [Related]
38. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
[TBL] [Abstract][Full Text] [Related]
39. Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuria.
Rizzieri DA; Walsh K
Clin Adv Hematol Oncol; 2012 Feb; 10(2):136-7. PubMed ID: 22402360
[No Abstract] [Full Text] [Related]
40. Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Öneç B; Öneç K; Esbah AÜ; Esbah O
Turk J Haematol; 2016 Dec; 33(4):362-363. PubMed ID: 27095140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
